Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by bealerton Oct 09, 2019 10:45pm
140 Views
Post# 30215022

DON and PANDORA

DON and PANDORAThey need to give a hint of upfront payments so that investors don't fear another PP to soon, also some hint or range of royalties expected, and possibly a range of targeted sales. Any numbers that would interest investors to bring more reality to these 'deals'. Now that a China deal is pending, they could hint at the R + F numbers at least. Too much strategic secrecy. Pandora, of course they won't read this chatter here but I am in contact with them often by email, but that is a slow process and they take a long time to answer even a few times. I have contacted them about information dissemination most recently and might get an answer soon. They seem to go into seclusion and always tell that things are moving along fine and I let my thoughts be known but they have their thoughts on how to proceed and they don't necessarily coincide with ours. Patience and gentle nudging is the best I can do for now. I think they are stretched very thin and answering to shareholders often takes a back seat. We will persist, however, and hope our investments reap huge rewards. GLTA Bealert
Bullboard Posts